Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up ...

Each year, Phesi releases an analysis of the world’s most studied diseases. The survey includes data from the 67,569 ...

Exposures to silica dust, solvents or heavy metals increase the likelihood of developing various forms of myositis, ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Dr Zaheer Mangera discusses the evolution of the neoadjuvant lung cancer pathway and notable changes to the TNM standards.

Prospective study on abemaciclib-induced interstitial lung disease in metastatic breast cancer reveals a 7.4% incidence rate.

Join Channel 13 and the American Lung Association to fight lung disease and Scale the Strat on Sunday, Feb. 23.

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, and it can shapeshift in unpredictable ways to evade treatment.

February is National Cancer Prevention Month 2025, which aims to bring awareness to the avoidable causes of cancer so people ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibrosis (IPF) drug with a second phase 3 win in ...

As temperatures drop, zip up that coat, pull on a hat and gloves and be mindful of how much time you’re exposed to the ...